Literature DB >> 1183034

The influence of drugs and disease activity on biochemical and haematological data in rheumatoid arthritis.

P Wilding, M J Kendall, R Holder, J A Grimes, M Farr.   

Abstract

Biochemical and haematological data from 218 patients with rheumatoid arthritis were analysed and compared with data from a reference hospital population. The comparison demonstrated significant differences in several biochemical and haematological tests and that the patterns of change are different between males and females. The data were also analysed by conventional statistical methods and discriminant analysis using a computer to establish which tests were most influenced by the activity of the disease and drug therapy. The results obtained demonstrate marked difference between groups of patients with different disease activity or receiving different drugs. The discriminant analysis also identified those tests which differentiate these groups most effectively.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1183034     DOI: 10.1016/0009-8981(75)90200-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Serum sulphydryl changes in rheumatoid coalworkers' pneumoconiosis patients treated with D-penicillamine.

Authors:  P H Evans
Journal:  Proc R Soc Med       Date:  1977

2.  A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients.

Authors:  M J Kendall; M C Chellingsworth; R Jubb; A R Thawley; N A Undre; D C Kill
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Gamma glutamyl transpeptidase levels in arthritis: a correlation with clinical and laboratory indices of disease activity.

Authors:  J R Lowe; M E Pickup; J S Dixon; P A Leatham; V M Rhind; V Wright; W W Downie
Journal:  Ann Rheum Dis       Date:  1978-10       Impact factor: 19.103

4.  Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.

Authors:  M Farr; D P Symmons; P A Bacon
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

5.  A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; V Wright
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

6.  Thrombocytosis of active rheumatoid disease.

Authors:  M Farr; D L Scott; T J Constable; R J Hawker; C F Hawkins; J Stuart
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

7.  Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  J S Dixon; M E Pickup; J R Lowe; C Hallett; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

8.  Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

Authors:  S Rantapää-Dahlqvist; S Wållberg-Jonsson; G Dahlén
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

9.  LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study.

Authors:  Yune-Jung Park; Chul-Soo Cho; Paul Emery; Wan-Uk Kim
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.